EQRx 将来の成長
Future 基準チェック /26
EQRx is forecast to grow revenue at 123.3% per annum.
主要情報
n/a
収益成長率
n/a
EPS成長率
Biotechs 収益成長 | 27.1% |
収益成長率 | 123.3% |
将来の株主資本利益率 | n/a |
アナリストカバレッジ | Low |
最終更新日 | 07 Oct 2023 |
今後の成長に関する最新情報
更新なし
Recent updates
We're Hopeful That EQRx (NASDAQ:EQRX) Will Use Its Cash Wisely
Jul 25EQRx (NASDAQ:EQRX) Is In A Good Position To Deliver On Growth Plans
Feb 22We're Not Very Worried About EQRx's (NASDAQ:EQRX) Cash Burn Rate
Nov 08EQRx: Saving American Lives, Made Possible By Low Cost Chinese Drugs
Aug 28 EQRx GAAP EPS of -$0.17 beats by $0.03
Aug 11Here's Why We're Not Too Worried About EQRx's (NASDAQ:EQRX) Cash Burn Situation
Jul 24We Think EQRx (NASDAQ:EQRX) Can Afford To Drive Business Growth
Apr 08EQRx (NASDAQ:EQRX) Is In A Good Position To Deliver On Growth Plans
Dec 24業績と収益の成長予測
日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
---|---|---|---|---|---|
12/31/2025 | 3 | N/A | N/A | N/A | 1 |
12/31/2024 | 1 | N/A | N/A | N/A | 1 |
12/31/2023 | N/A | N/A | N/A | N/A | 1 |
9/30/2023 | N/A | -260 | -332 | -330 | N/A |
6/30/2023 | N/A | -263 | -332 | -330 | N/A |
3/31/2023 | N/A | -272 | -320 | -319 | N/A |
12/31/2022 | N/A | -169 | -288 | -287 | N/A |
9/30/2022 | N/A | -146 | -262 | -262 | N/A |
6/30/2022 | N/A | -100 | -242 | -242 | N/A |
3/31/2022 | N/A | -53 | -214 | -214 | N/A |
12/31/2021 | N/A | -100 | -184 | -183 | N/A |
9/30/2021 | N/A | -279 | -276 | -275 | N/A |
6/30/2021 | N/A | -296 | -289 | -286 | N/A |
3/31/2021 | N/A | -269 | -260 | -257 | N/A |
12/31/2020 | N/A | -250 | -244 | -242 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: Insufficient data to determine if EQRX's forecast earnings growth is above the savings rate (2.2%).
収益対市場: Insufficient data to determine if EQRX's earnings are forecast to grow faster than the US market
高成長収益: Insufficient data to determine if EQRX's earnings are expected to grow significantly over the next 3 years.
収益対市場: EQRX's revenue (123.3% per year) is forecast to grow faster than the US market (8.1% per year).
高い収益成長: EQRX's revenue (123.3% per year) is forecast to grow faster than 20% per year.
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: Insufficient data to determine if EQRX's Return on Equity is forecast to be high in 3 years time